Second-Line Therapy in Extranodal Marginal Zone Lymphoma

home / case-based-peer-perspectives / noy-extranodal-mzl

Second-Line Therapy in Extranodal Marginal Zone Lymphoma

Managing Extranodal MZL

EP. 1: Managing Extranodal MZL

August 27th 2018

Watch

Considerations for Diagnosing MZL

EP. 2: Considerations for Diagnosing MZL

August 27th 2018

Watch

First-Line Therapy in Advanced MZL

EP. 3: First-Line Therapy in Advanced MZL

August 27th 2018

Watch

Advanced MZL: First-Line Treatment Considerations

EP. 4: Advanced MZL: First-Line Treatment Considerations

August 27th 2018

Watch

Second-Line Therapy in Advanced MZL

EP. 5: Second-Line Therapy in Advanced MZL

August 27th 2018

Watch

Ibrutinib As Second-Line Therapy in Refractory MZL

EP. 6: Ibrutinib As Second-Line Therapy in Refractory MZL

August 27th 2018

Watch

MZL: Managing Patients Who Receive Ibrutinib

EP. 7: MZL: Managing Patients Who Receive Ibrutinib

August 27th 2018

Watch